Author: Ravi Shankar

Ness Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) —

• Record first half revenue of $1.55 million, up 438%, at a 61% gross margin, all generated by the AME and Quantum segment in its first 86 days after being acquired by QTREX
• INSU300, the first native RF dielectric developed specifically for superconducting quantum computing, launched September 23, 2026, with a dedicated AME system; initial deployments at two government and defense organizations for validation in their own systems
• Company expects to announce additional commercial agreements in the fourth quarter and to provide a 2027 financial outlook

QTREX Quantum Ltd. (Nasdaq: QTEX) (“QTREX” or the “Company”), a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, today reported financial results for the six months ended June 30, 2026, and provided a business update.

Revenue reached a record $1.55 million, up approximately 438% from $289,000 in the first half of 2025, with a consolidated gross margin of 61%. All revenue was generated by the AME and Quantum segment in its first 86 days under QTREX following the acquisition on April 6, 2026. The year-over-year comparison reflects the addition of the acquired business. The Company expects to announce additional commercial agreements during the fourth quarter and, in the same quarter, to provide a financial outlook for 2027.

First Half 2026 Financial Highlights

• Completed the acquisition of the AME platform on April 6, 2026 for $2.0 million in cash at closing, with contingent consideration payable only out of net cash collected from the sale of inventory and property acquired with the business over the following twelve months.
• Revenue of $1.55 million comprised $1.24 million from products and $313,000 from services, all within the AME and Quantum segment.
• Consolidated gross profit of $944,000, representing a gross margin of approximately 61%.
• Cash, cash equivalents and deposits of $10.7 million on June 30, 2026, compared with $3.2 million on December 31, 2025.
• Net cash used in operating activities of $3.9 million, compared with $5.1 million in the first half of 2025.

Business Highlights

The Company is using its acquired AME platform to develop proprietary materials and integrated cryogenic components that address the thermal load, wiring density and signal integrity challenges of scaling superconducting quantum computers. Progress since the acquisition:

• Progress with a leading quantum computing company. Following the joint technical evaluation announced on May 21, 2026, with one of the world’s five leading quantum computing companies, additional requirements have been agreed and several stages of testing completed on parameters required for its systems.
• INSU300 launch and validation deployments. Launched INSU300 and a dedicated AME system on September 23, 2026, meeting the target set in August. The material is being provided to two government and defense organizations for validation and testing within their own systems.
• Industry presence. Presented the interconnect architecture designed to support 17,280 coaxial lines per cryogenic stage at IEEE Quantum Week in Toronto, and exhibited the multistage demonstrator built with INSU300 at Quantum World Congress in College Park, Maryland.
• Transition to customer production. One of the largest U.S. interconnect manufacturers, with established product lines for quantum computing applications, moved its AME system from development to production following a validation program in which the manufacturing process achieved a 97% yield.
• Quantum infrastructure components. Received a commercial order for customized shielded RF monolithic components from a leading government-owned international company and began production. Separately, produced a cryogenic chip carrier to the specifications of one of the world’s largest U.S.-based technology companies developing full-stack quantum computing systems.
• Government and defense activity. QTREX AME systems operate at two U.S. government laboratories with quantum programs. On September 2, 2026, the Company announced that one of Israel’s three largest defense companies had begun deployment of its AME technology under a phased program.

CEO Update

Dagi Ben-Noon, Chief Executive Officer of QTREX, commented:

“Less than two months after entering quantum computing, QTREX had already begun a joint technical evaluation with one of the world’s five leading quantum computing companies. Since then, we have agreed additional requirements and completed several testing stages addressing specific parameters of its systems, advancing toward the performance and integration requirements of a partner at this level.

“In less than six months, we have built a network of customers and collaborators that includes Qarakal Quantum, U.S. government laboratories, defense companies and organizations, and academic institutions. This pace is the direct result of acquiring a business our leadership knows inside and out. That operational knowledge enabled seamless integration of its technology, people and manufacturing capabilities into QTREX and immediate execution of our quantum strategy.

“With INSU300, we launched the material and the dedicated system on the timetable we set. The initial deployments at two government and defense organizations are for validation within their own systems. For future commercial deployments, our model is to provide the system and sell the material customers consume. Our objective is to convert successful validation into ongoing commercial use, expand installations and grow material sales as customers increase their activity.

“We are building QTREX to become a dominant technology provider for superconducting quantum computing. Bringing proprietary materials, manufacturing processes and component design into one platform opens multiple paths for integration across the hardware of these systems. Our strategy is to embed QTREX technology in critical parts of the quantum computer and continually expand the range of functions we can deliver.

“Our development work is already addressing thermal load, signal integrity and the physical constraints of scaling these systems. We are using our manufacturing capabilities and working with partners to advance new materials and integrated components from design through testing and qualification. Our current products and commercial activity provide the foundation for this broader research and development effort and the business we intend to build around it.

“We are advancing ongoing technical and commercial discussions with several of the largest companies in quantum computing about supplying our cryogenic connectivity and meeting their integration requirements. Our participation in IEEE Quantum Week and Quantum World Congress this month supported this ongoing work through further technical exchanges and introductions to additional organizations. In parallel, we are working on transactions that would add established revenue and manufacturing capability to QTREX.

“The pace we have established sets the bar for what comes next, and what we have announced so far is a small part of what is in motion. I expect to announce additional commercial agreements during the fourth quarter, when we will also provide our 2027 financial outlook describing a substantially larger business than the one we report today. I expect the next twelve months to bring significant revenue growth, strategic partnerships, broader customer adoption and increased product deliveries.”

Financial Results

Revenue for the six months ended June 30, 2026 included $1.24 million from sales of AME systems, proprietary inks, other consumables and spare parts, and $313,000 from installation, training, support and maintenance services. Gross margin reflected the mix of systems, consumables and services recognized during the period.

Total operating expenses were $7.9 million, compared with $7.2 million in the first half of 2025. The increase primarily reflected research and development expenses associated with the acquired AME and Quantum operations, partly offset by lower general and administrative expenses, primarily lower share-based compensation.

The AME and Quantum segment recorded operating expenses of $2.4 million and an operating loss of $1.4 million in its first 86 days under QTREX. The Medical Technology segment, which recorded no revenue and also carries corporate and public company costs, accounted for the remaining $5.5 million of operating loss. The Company continues to pursue transactions to monetize its medical technology assets.

Consolidated operating loss was $6.9 million, compared with $7.2 million in the first half of 2025. Net loss was $6.4 million, or $0.14 per share, compared with $6.4 million, or $0.24 per share.

Cash Position and Financing

Cash, cash equivalents and deposits totaled $10.7 million at June 30, 2026, compared with $3.2 million at December 31, 2025.

Net cash used in operating activities was $3.9 million, compared with $5.1 million in the first half of 2025. Operating cash flow included the effects of a $2.1 million increase in other accounts payable, a $573,000 increase in accounts receivable and a $443,000 decrease from sale of inventory during the period.

Net cash used in investing activities was $2.0 million, primarily consisting of the cash paid at the closing of the AME and Quantum acquisition. Net cash provided by financing activities was $13.5 million, principally from the registered direct offering completed in February 2026 and the private placement offering completed on June 1, 2026.

On August 20, 2026, after the period end, the Company conducted a registered direct offering consisting of 11,111,111 ordinary shares sold at a purchase price of $0.90 per share, raising approximately $10 million in gross proceeds and approximately $9.2 million net of offering costs. These proceeds are not included in the June 30 cash balance.

Further discussion of liquidity and capital resources is included in the Management’s Discussion and Analysis furnished with the Company’s Report on Form 6-K.

Outlook

The Company expects the fourth quarter of 2026 to be its most active commercial period to date. It expects to announce additional commercial agreements during the quarter and, in the same quarter, to provide a financial outlook for 2027 that reflects a substantially larger business. In addition, the Company has completed a joint work plan with a U.S. national laboratory and is targeting formalization of the collaboration during the quarter, subject to the laboratory’s review and approval process.

Selected Financial Information

Unaudited. U.S. dollars in thousands, except share and per share data. To be read together with the Company’s unaudited condensed interim consolidated financial statements and notes for the six months ended June 30, 2026, furnished on Form 6-K.

Unaudited Condensed Consolidated Statements of Comprehensive Loss

				Six months ended June 30,						Six months ended June 30,
				2026						2025
Revenues						1,554						289
Cost of revenues						(610		)				(287		)
Gross Profit						944						2
Research and development expenses						(4,760		)				(3,638		)
General and administrative expenses						(2,594		)				(3,150		)
Sales and marketing expenses						(545		)				(442		)
Other income (expenses)						19						(7		)
Operating loss						(6,936		)				(7,235		)
Interest income from deposits						22						37
Finance income (income), net						560						800
Loss before tax						(6,354		)				(6,398		)
Taxes on income						–						–
Total comprehensive and net loss						(6,354		)				(6,398		)
Net loss per ordinary share, basic and diluted						(0.14		)				(0.24		)
Weighted average number of ordinary shares						44,566,144						26,782,603

Unaudited Condensed Consolidated Balance Sheet Data

			June 30,				December 31,
			2026				2025
ASSETS
Current Assets:
Cash and cash equivalents				10,666				3,159
Accounts receivable				825				–
Other current assets				738				517
Inventory				2,812				735
Total current assets				15,041				4,411
Non-Current Assets:
Right of use assets, net				2,742				478
Property, plant and equipment, net				2,528				452
Total non-current assets				5,270				930
Total Assets				20,311				5,341
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Trade accounts payable				466				107
Contingent consideration liability				996				–
Deferred revenue				1,004				–
Other accounts payable				3,519				1,349
Lease liabilities				1,545				286
Financial liabilities at fair market value				–				1,082
Total current liabilities				7,530				2,824
Non-Current Liabilities:
Lease liabilities				1,249				194
Deferred revenue				196				–
Royalty-bearing grant liability				597				–
Total non-current liabilities				2,042				194
Total Shareholders’ Equity				10,739				2,323
Total Liabilities and Shareholders’ Equity				20,311				5,341

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for quantum computing and other advanced hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses negotiations and potential entry into definitive agreements; its expectation to announce additional commercial agreements in the fourth quarter and to provide a 2027 financial outlook; the progress and timing of its various projects with its customers and collaborating partners; the progress of its joint technical evaluation with one of the world’s five leading quantum computing companies; its belief that its business pace is the direct result of acquiring a business its leadership knows inside and out and that operational knowledge enabled seamless integration of its technology, people and manufacturing capabilities into QTREX and immediate execution of its quantum strategy; its future commercial deployments and expected business model; its plans to develop proprietary materials, high-density interconnects and integrated cryogenic components to address the thermal load, wiring density and signal integrity challenges of scaling superconducting quantum computers; its objective to become a dominant technology provider for superconducting quantum computing; its strategy to integrate proprietary materials, manufacturing processes and advanced components into multiple critical parts of these systems and continually expand the range of functions its platform can deliver; its discussions with quantum computing companies and potential transactions intended to add established revenue and manufacturing capability; its target to formalize a collaboration with a U.S. national laboratory in the fourth quarter, subject to the laboratory’s review and approval process; its view that the pace it has established in its first six months sets the bar for what comes next, and that what it has announced so far is a small part of what is in motion; its expectation to announce additional commercial agreements during the fourth quarter and that the next twelve months will bring significant business growth, strategic partnerships, broader customer adoption and increased product deliveries; its expectation that its 2027 outlook will describe a business substantially larger than the one it reports today, and that what it has achieved in its first six months is the groundwork for that expansion; and its expectation that the fourth quarter of 2026 will be its most active commercial period to date. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485

BOISE, Idaho, Sept. 24, 2026 (GLOBE NEWSWIRE) — Idaho Copper Corporation (NYSE American: COPR) (“Idaho Copper” or the “Company”), a critical minerals developer advancing the flagship CuMo copper-molybdenum-silver project in Idaho, today announced that Chief Executive Officer Andrew Brodkey will serve as a featured panelist at the 2026 Mining and Energy Expo, presented by Better In Our Back Yard (BIOBY), taking place September 29 – October 2, 2026, in Bloomington, Minnesota.

Mr. Brodkey will appear on a panel focused on mining in Idaho on Thursday, October 1, 2026. Now in its second year, the Mining and Energy Expo convenes the decision-makers and leaders shaping policy, infrastructure, and investment across the mining and energy sectors, providing a forum to advance domestic critical mineral development and connect industry, investors, and policymakers. Details of Mr. Brodkey’s participation are as follows:

2026 Mining and Energy Expo
Session: Idaho Mining Panel
Date: Thursday, October 1, 2026
Location: Bloomington, Minnesota
Registration: betterinourbackyard.com/mining-and-energy-expo

Andrew Brodkey, Chief Executive Officer of Idaho Copper, commented, “We are honored to take part in the BIOBY Mining and Energy Expo and to represent Idaho on a panel dedicated to responsible mining in our state. This comes at a pivotal time for Idaho Copper, following the recent approval to commence drilling for our flagship CuMo project. Conferences like these bring together the industry leaders, investors, and policymakers who are shaping the future of domestic critical mineral supply, and they offer an important platform to raise awareness of the CuMo project and the role Idaho can play in strengthening America’s copper and molybdenum supply chains. We look forward to sharing our story and continuing to build visibility for Idaho Copper following our recent listing on the NYSE American exchange.”

About Idaho Copper Corp.

Idaho Copper Corporation (NYSE American: COPR) is a critical minerals developer focused on exploring and developing the CuMo copper-molybdenum-silver project located in Boise County, Idaho. The CuMo project is one of the largest undeveloped copper deposits in the western hemisphere, which management believes is among the largest undeveloped molybdenum deposits in the world, and contains significant amounts of silver, rhenium, and tungsten—all considered critical or of strategic importance. The project comprises approximately 2,640 acres and consists of 126 federal unpatented lode mining claims and 6 patented mining claims. To learn more, please visit www.idaho-copper.com.

Safe Harbor Statement

With the exception of historical information contained in this press release, content herein may contain “forward-looking statements” that are made pursuant to the Safe Harbor Provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified by using words such as “anticipate,” “believe,” “plan,” “expect,” “intend,” “will,” and similar expressions, but these words are not the exclusive means of identifying forward-looking statements. Forward-looking statements in this release include statements regarding Idaho Copper’s participation in the 2026 Mining and Energy Expo and statements relating to expected developments and growth in Idaho Copper’s business. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. In addition, this press release contains time-sensitive information that reflects management’s best analysis only as of the date of this press release. Idaho Copper does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release. Further information concerning issues that could materially affect financial performance or other forward-looking statements contained in this release can be found in Idaho Copper’s periodic filings with the SEC.

Investor Relations Contact
Lucas A. Zimmerman
Managing Director
MZ Group – MZ North America
(262) 357-2918
COPR@mzgroup.us
www.mzgroup.us

LONDON, September 24, 2026 – Stolt-Nielsen Limited (Oslo Børs: SNI) will host a virtual presentation to discuss the Company’s unaudited results for the third quarter and first nine months of 2026 on Thursday, October 1, 2026 at 15:00 CEST (09:00 EDT, 14:00 BST).

The virtual presentation will be hosted by:

–          Udo Lange – Chief Executive Officer, Stolt-Nielsen Limited 
–          Alex Ng – Chief Financial Officer, Stolt-Nielsen Limited

To join the event online, please click here.

The link will also be available on our website. It may be necessary to download the Teams app to join by mobile phone, although attendees should not need to log in or create an account.

The presentation slides will be published on the Investor section of our website (www.stolt-nielsen.com) on the day of the presentation.

For additional information please contact:

Alex Ng
Chief Financial Officer

Kirsty MacCallum
Head of Corporate Communications

T: +44 207 611 8960
investors@stolt.com

About Stolt-Nielsen Limited
Stolt-Nielsen (SNL or the ‘Company’) is a long-term investor and manager of businesses focused on opportunities in logistics, distribution and aquaculture. The Stolt-Nielsen portfolio consists of its three global bulk-liquid and chemicals logistics businesses – Stolt Tankers, Stolthaven Terminals and Stolt Tank Containers – Stolt Sea Farm and various investments. Stolt-Nielsen Limited is listed on the Oslo Stock Exchange (Oslo Børs: SNI).

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Discussion highlights land-and-expand execution, expansion into new verticals, and commercial scaling initiatives

PALO ALTO, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“Cloudastructure” or the “Company”), a leader in cloud-native AI surveillance and remote guarding, today announced that James McCormick, Chief Executive Officer, and other members of the Company’s management team, participated in a fireside chat hosted by James Kisner, Managing Director at Water Tower Research on Tuesday, September 22, 2026, at 3:30 pm ET. During the discussion, management highlighted several strategic initiatives, including:

• Existing Account Expansion: Long-term opportunity to expand deployments within relationships with eight of the ten largest U.S. multifamily property managers, creating a significant runway for growth within existing enterprise customers.
• New Vertical Growth: Expansion into construction, commercial real estate, and transportation and logistics, leveraging the Company’s core AI-powered surveillance and remote guarding platform.
• Recurring Revenue Growth: Continued growth in subscription revenue is expected to support long-term margin expansion and operating leverage while maintaining disciplined spending.
• Commercial and Operational Scaling: CRO Nile Coates and CSOO Ed Burnett are leading initiatives to expand key verticals, strengthen strategic partnerships, establish master service agreements and scale the Company’s commercial and operational capabilities.

A replay of the fireside chat is now available on demand in the Investor Relations section of Cloudastructure’s website here.

To schedule a one-on-one meeting with Cloudastructure’s management team, please email KCSA Strategic Communications at Cloudastructure@KCSA.com.

About Cloudastructure, Inc.
Headquartered in Palo Alto, California, Cloudastructure’s patented, advanced, award-winning security platform utilizes a scalable cloud-based architecture that features cloud video surveillance with proprietary, state-of-the-art AI/ML analytics, and a seamless remote guarding solution. The combination enables enterprise businesses to achieve proactive, end-to-end security, and pairs that platform with an attractive value proposition that eschews proprietary hardware and offers contract-free, month-to-month pricing and unlimited 24/7 support. With Cloudastructure, companies can achieve unparalleled situational awareness in real time and thereby stop crime as it is happening, while simultaneously achieving up to a 75% lower Total Cost of Ownership than other systems. For more information, visit https://www.cloudastructure.com/.

Forward-Looking Statements
Certain statements in this press release may be considered forward-looking, such as statements containing estimates, projections, and other forward-looking information. Forward-looking statements are typically identified by words and phrases such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “seek,” “should,” “will,” “would,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target” or the negative of such words and other comparable terminology. However, the absence of these words does not mean that a statement is not forward-looking. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and involve risks, uncertainties, and other factors beyond our control. Therefore, we caution you against relying on any of these forward-looking statements. Factors that could cause or contribute to such differences include the risks and uncertainties discussed in the reports that the Company has filed with the SEC, such as its Annual Report on Form 10-K. Actual outcomes and results may differ materially from what is expressed in any forward-looking statement. Except as required by applicable law, including U.S. federal securities laws, we do not intend to update any of the forward-looking statements to conform them to actual results or revised expectations.

Media Contact:
Kathleen Hannon
Sr. Communications Director
Cloudastructure, Inc.
704.574.3732
Kathleen@cloudastructure.com

Investor Contact:
Valter Pinto
Managing Director
KCSA Strategic Communications
212.896.1254
Cloudastructure@KCSA.com

WILMINGTON, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (NASDAQ: DETX; TSXV: SCAN), a leading technology provider of AI-based, next-generation detection solutions for concealed weapons and threats, today announced the execution of a strategic, non-exclusive distribution agreement with VMI Security.

VMI Security is a recognized leader in non-intrusive security inspection solutions, serving a broad range of market verticals, including aviation, critical infrastructure, government, and public venues. The agreement expands Liberty’s U.S. sales channel network and strengthens the Company’s ability to address the large and growing demand for total security screening applications.

Under the agreement, VMI will offer Liberty’s HEXWAVE™ walkthrough screening system as part of its security solutions portfolio. HEXWAVE combines advanced artificial intelligence and machine learning with active sensing technology to detect metallic and non-metallic weapons, explosives, and other emerging threats in real time, while enabling a high-throughput, frictionless screening experience.

The partnership provides Liberty with access to VMI’s established customer relationships, extensive sales infrastructure, and deep expertise across airports, critical infrastructure, public venues, and other security-sensitive environments. VMI’s established market presence and ability to integrate multiple security technologies into comprehensive screening solutions are expected to enhance Liberty’s ability to introduce HEXWAVE to new customers and support additional commercial opportunities.

“The partnership with VMI Security comes at a critical time for the expanding US security screening market,” said Bill Frain, CEO of Liberty Defense. “VMI has a proven track record of delivering next-generation security inspection technologies and the ability to provide customers with end-to-end checkpoint screening solutions, now including HEXWAVE. We believe the combination of VMI’s security expertise and customer reach with Liberty’s AI-enabled detection capabilities creates a compelling opportunity to expand the adoption of HEXWAVE in high-value security applications.

“We are extremely excited to add HEXWAVE to VMI’s growing portfolio of security screening solutions,” said Scott Ortolani, COO of VMI Security. “I have personally followed the development of HEXWAVE since its introduction to the market, watching the technology evolve and the product demonstrate its capabilities in real-world security environments. I have been consistently impressed by both the technology and Liberty Defense’s vision for what advanced, high-throughput screening can become.

The Company also announces that on September 24, 2026, it granted an aggregate of 43,888 restricted share units (the “RSUs”) to certain directors and officers of the Company pursuant to the Company’s Omnibus Long-Term Incentive Plan dated for reference November 6, 2025 (the “Plan”). Of the RSUs granted, 23,888 RSUs vest on September 24, 2027, and 20,000 RSUs vest on September 24, 2028. All RSUs have an expiry date of September 24, 2031. Each RSU entitles the holder to receive one common share of the Company upon vesting and settlement.

For updates and news, please visit the Company website to subscribe to email alerts or follow Liberty Defense on social channels.

About Liberty Defense
Liberty Defense (NASDAQ: DETX; TSXV: SCAN) provides multi-technology security solutions for concealed weapons detection in high volume foot traffic areas and locations requiring enhanced security such as airports, stadiums, schools, and more. Liberty’s HEXWAVE product, for which the Company has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement for patents related to active 3D radar imaging technology, provides discrete, modular, and scalable protection to provide layered, stand-off detection capability of metallic and non-metallic weapons. Liberty has also recently licensed the millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe scanner technologies as part of its technology portfolio. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions.

For updates and news, please visit the Company website to subscribe to email alerts or follow Liberty Defense on social channels.

ABOUT VMI Security
VMI Security is one of the world leaders in manufacturing and developing X-ray inspection technologies. With non-intrusive inspection solutions that aim to strengthen control and security systems, VMI stands out for developing high-quality equipment and for its continuous support services.

For sales information, please contact:

Ian McNaughton
Senior Director Business Development, Liberty Defense
613-292-3669
imcnaughton@libertydefense.com

FORWARD-LOOKING STATEMENTS
When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because Liberty can give no assurance that such statements will prove to be correct. Such statements and information reflect the current view of Liberty.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. There are a number of important factors that could cause Liberty’s actual results to differ materially from those indicated or implied by forward-looking statements and information, including those appearing in Liberty’s public filings. Such factors include, among others: currency fluctuations; limited business history of Liberty; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; general development, market and industry conditions; and other factors described in Liberty’s public filings. Liberty undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of its securities or its financial or operating results (as applicable).

Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

MindWave will supply and operate the technology, while AQUAE leads the ALCI Credits methodology, brand and market development

MATAWAN, New Jersey, Sept. 24, 2026 (GLOBE NEWSWIRE) — via IBN — MindWave Innovations Inc. (“MindWave”), a subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has signed a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. (“AQUAE”) to deploy its MindChain infrastructure as the foundation of AQUAEChain, a platform for insured ALCI Credits.

Under the agreement, MindWave will design, develop, deploy and host AQUAEChain, and provide technical support once it is live. The platform will manage the full life of an ALCI Credit: issuance, verification, tracking, transfer and retirement.

MindWave will earn contracted software development and technology service fees. The agreement also references an allocation to MindWave equal to 20% of the total ALCI Credits issued and outstanding on the AQUAEChain network, calculated at the end of each quarter using the MindChain issuance ledger.

The two companies have divided the work along clear lines. AQUAE will lead the ALCI Credits methodology, brand, business development, partner relationships and ecosystem engagement. MindWave will provide the underlying technology infrastructure and the ongoing technical services required to operate AQUAEChain.

For MindWave, the engagement represents an important expansion of its business. It extends the company’s technology business into environmental and sustainability-focused markets and shows its ability to design, build and operate specialized digital infrastructure for a client over the long term.

AQUAEChain will bring blockchain infrastructure, an ALCI Credits registry, monitoring, reporting and verification (MRV) data management, a marketplace and insurance-related features together in one platform. The MRV tools will collect and analyze project information, including satellite and ground-source data. The marketplace will support the listing, trading and settlement of ALCI Credits between AQUAE and its counterparties.

All issued and outstanding credits will be recorded on the MindChain issuance ledger, giving AQUAE and its partners a traceable record from issuance to retirement. MindWave will host the platform in a cloud environment designed for availability, operational continuity and future growth, with administrative, technical and physical safeguards protecting platform data and transaction records.
The companies’ shared aim is a secure, transparent, traceable and scalable digital market for nature-based assets, with the methodology and market relationships led by AQUAE and the technology built and run by MindWave.

“Being chosen by AQUAE to build the technology foundation for its ecosystem-finance business shows what MindWave can deliver beyond traditional software development,” said Dr. Vin Menon, Chief Executive Officer of MindWave Innovations. “Registry, environmental data, verification and trading will sit on a single platform, and the MindChain ledger means each ALCI Credit can be traced through its entire lifecycle.”

“AQUAEChain is central to our plan for ecosystem-finance infrastructure that the market can depend on,” said Linju Thomas, Chief Operating Officer of AQUAE Holdings.

“MindWave gives us a scalable platform for managing ALCI Credits, so our team can concentrate on the methodology, our partners and the conservation and regenerative-sustainability initiatives behind each credit.”

The agreement took effect on Sept. 14, 2026, with development and delivery tied to agreed project milestones. During the initial 12-month term, MindWave will provide platform hosting, infrastructure maintenance, technical escalation support and embedded engineering assistance, working with AQUAE’s technical team on configuration, deployment and operational readiness.

After the initial term, the parties expect to move to a five-year continuing technology services arrangement, subject to mutual agreement and the execution of definitive documentation.

About MindWave Innovations Inc.

MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), develops technology infrastructure and digital solutions for blockchain-enabled applications, data-driven platforms, and emerging commercial ecosystems.

Through projects such as AQUAEChain, MindWave is expanding the application of its technology into ecosystem finance, environmental data management, and sustainability-focused markets.

For more information, visit www.mindwavedao.com.

About MindChain

MindChain is a blockchain infrastructure developed within the MindWave ecosystem to support transparent, traceable, and verifiable digital transactions. It is designed to provide the underlying ledger capabilities required for applications involving digital assets, registries, tokenized ecosystems, and decentralized services.

Within AQUAEChain, the MindChain issuance ledger will be used to record and calculate ALCI Credits issued and outstanding, strengthening transparency and traceability across the credit-management process.

About AQUAE Holdings Pte. Ltd.

AQUAE Holdings Pte. Ltd. is a Singapore-based company focused on technology-driven solutions in ecosystem finance, conservation, and regenerative sustainability. The company is developing AQUAEChain to support its ALCI Credits and ecosystem-finance operations.

For more information, visit www.aquaeimpact.com.

About ALCI

The AQUAE Labs Ecosystems Conservation Index (ALCI) is a comprehensive field-based monitoring recording and verification (MRV) framework designed to evaluate the biomass, biodiversity, and ecological functionality of terrestrial ecosystem types following the approach defined by the IUCN and other replicable scientific approaches.

Forward-Looking Statements

This announcement contains forward-looking statements regarding the development, implementation, anticipated capabilities, and potential performance of the AQUAEChain Platform, the integration and operation of MindChain, and the potential issuance and allocation of ALCI Credits. These statements are based on current expectations and are subject to risks and uncertainties, including development timelines, achievement of project milestones, technical performance, regulatory requirements, issuance volumes, and market acceptance. Actual results may differ materially from those expressed or implied. The company undertakes no obligation to update these statements except as required by applicable law.

Media:

MindWave Innovations Inc.

contact@mindwaveinnovations.com

Corporate Communications:

IBN

Austin, Texas

IBN.Ai

512.354.7000 Office

Editor@IBN.Ai

European patent strengthens protection for proprietary autonomic nervous system assessment technologies, further expanding Company’s international patent portfolio

THE WOODLANDS, TX, Sept. 24, 2026 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the grant of European Patent No. EP 4 233 700 B1, titled “Systems for Assessing Neural Activity in an Eye.” The newly issued patent further expands the Company’s international intellectual property portfolio and strengthens protection for technologies supporting autonomic nervous system assessment and precision neuromodulation across Europe.

The European patent covers technologies designed to assess autonomic nervous system activity through the monitoring and analysis of neural activity within the eye. The patent includes systems and methods for evaluating physiologic responses through ocular measurements that may support patient assessment, treatment guidance and procedural feedback across a variety of autonomic nervous system disorders and neuromodulation applications.

“This European patent represents another important step in expanding our global intellectual property footprint,” said Brad Hauser, Chief Executive Officer of Autonomix. “As we continue advancing our precision nerve-targeted technology platform, building a broad international patent portfolio remains a key strategic priority. This patent enhances protection for technologies supporting autonomic nervous system assessment and complements our growing portfolio covering precision nerve sensing, mapping and targeted neuromodulation.”

The granted patent complements Autonomix’s expanding portfolio of issued and pending patents protecting technologies spanning autonomic nervous system assessment, neural sensing, treatment guidance and transvascular neuromodulation. Together, the Company’s growing international patent estate supports its strategy of developing differentiated technologies designed to precisely identify, assess and target disease-associated nerves across multiple therapeutic applications.

Autonomix continues to advance its proprietary technology platform designed to detect and differentiate neural signals with significantly greater sensitivity than conventional technologies, supporting the development of precision nerve-targeted therapies intended to improve patient outcomes while minimizing unintended effects on surrounding tissue.

About Autonomix Medical, Inc. 

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. 

We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. 
 
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.

Forward Looking Statements 

Some of the statements in this release are “forward-looking statements,” which involve risks and uncertainties. Such forward-looking statements can be identified by the use of words such as “should,” “might,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.” Forward-looking statements in this press release include, but are not limited to, expectations regarding the potential effectiveness and clinical benefits of Autonomix’s nerve-targeted treatments for pancreatic cancer pain and other conditions, the versatility and scalability of the Company’s platform technology, the potential for future clinical applications across multiple organ systems, the strength and scope of the Company’s intellectual property portfolio, and the potential for the Company’s patented technologies to support patient selection, procedural guidance and post-treatment monitoring across multiple neuromodulation applications. 
 
Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in the most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 27, 2026, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of this press release and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law. 

Investor and Media Contact 

JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com

YPB by Abercrombie launches new line in collaboration with the fitness experts at Barry’s

NEW ALBANY, Ohio, Sept. 24, 2026 (GLOBE NEWSWIRE) — Abercrombie & Fitch (Abercrombie), a division of Abercrombie & Fitch Co. (NYSE: ANF), announced a partnership between the brand’s activewear brand, YPB (Your Personal Best), and Barry’s, the original high-intensity interval workout studio. The multi-season collaboration brings together Abercrombie’s style authority and Barry’s authentic performance expertise through a collection designed to move seamlessly from workouts to life beyond the studio.

The partnership introduces YPB to Barry’s highly engaged community while also giving Abercrombie customers new ways to incorporate studio-ready activewear into their everyday wardrobes. The first collection, featuring performance fabrics, versatile silhouettes and functional layers, includes six styles for men and 12 styles for women. The collection will be available beginning Thursday, October 1, 2026, at Abercrombie.com and in select Abercrombie stores, followed by Barrys.com and 75 Barry’s locations globally on October 15, 2026.

With fit and design input from Barry’s instructors Jon Herrmann, Amy Harioka and Lacy Mitchell and inspired by Barry’s iconic Red Room, the capsule features bold red accents that reflect the energy of the space, balanced by black and neutral tones that make the pieces easy to wear before, during and after class. The collection reflects how both communities move through their day, balancing performance, versatility and style in pieces made to transition from a workout to what comes next.

The partnership will also come to life through a series of in-person activations designed to integrate YPB directly into the Barry’s community. YPB by Abercrombie will serve as the first official sponsor of Barry’s newly launched Mobile Studio, partnering on a pop-up experience in Austin, Texas, on October 2 and 3, 2026, coinciding with Austin City Limits. Guests will have an opportunity to preview the YPB by Abercrombie x Barry’s collection on-site. The experience will then continue in New York City, where YPB by Abercrombie x Barry’s will take over Barry’s NoHo studio from October 9 through 11, 2026. Guests can sign up for all upcoming classes at Barrys.com and on the Barry’s app.

“At Abercrombie, we’re focused on outfitting our customers for every part of their lives, including the moments when they’re moving, training and feeling their best,” said Corey Robinson, brand president of Abercrombie & Fitch. “Barry’s has built an incredibly engaged community around performance and connection, making this partnership a natural fit for YPB. Working directly with Barry’s instructors helped us create a collection rooted in real workout experience, with the style and versatility our customers expect from Abercrombie.”

“YPB by Abercrombie brings an innovative perspective to activewear, pairing elite performance with the effortless and timeless style Abercrombie is known for,” said J.J. Gantt, Barry’s CEO. “This meaningful collaboration brings together two iconic brands that started with Barry’s instructors playing a role in the design and creation of the pieces, ensuring the Barry’s community can experience high-performance pieces designed to support them both inside and outside the Red Room.” 

The YPB by Abercrombie x Barry’s collection comes in women’s styles in sizes XXS–XXL and men’s styles in sizes XS–XXL for tops and bottoms.

About Abercrombie & Fitch:
Abercrombie & Fitch is an effortless, elevated American lifestyle brand, blending heritage and modern style through quality apparel, accessories and fragrance crafted for all of life’s moments. Abercrombie & Fitch is the namesake brand of Abercrombie & Fitch Co. and is sold in more than 300 stores worldwide (including abercrombie kids) and on abercrombie.com globally.

About Barry’s:
Barry’s is the original high-energy cardio and strength interval training workout. Launched in 1998 in Los Angeles, it was the original pioneer in the global boutique fitness movement. Since then, it has grown from “The Best Workout in the World,” to become not just a fitness leader, but a community and lifestyle brand with innovative in-studio and digital class modalities, Fuel Bars, retail offerings, and a competitive loyalty program. With over 100 studios spanning 19 countries, plus its digital offering, Barry’s X, Barry’s now brings its global Fit Fam community with its signature Red Room workout experience both virtually and physically. Following the success of the original workout, Barry’s expanded its class offerings to include: LIFT (a 50-minute class focusing on strength training) and RIDE (a 50-minute class offering high-intensity interval training style indoor cycling paired with lifting.) Now a worldwide phenomenon with a cult-like following, Barry’s makes working hard and getting strong, fun. For more information, visit: https://www.barrys.com/.

Abercrombie Media Contact:
Public_Relations@anfcorp.com 

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/ec3e236b-d1a4-4e11-840d-2c96a200259f

https://www.globenewswire.com/NewsRoom/AttachmentNg/77ff58bc-72be-44a1-95c7-392604f36c77

https://www.globenewswire.com/NewsRoom/AttachmentNg/885bdf06-4284-4f24-b326-cbb3f650f2fc 

Singapore, Sept. 24, 2026 (GLOBE NEWSWIRE) — FBS Global Limited (Nasdaq: FBGL) (“FBS” or the “Company”) today announced that, at the extraordinary general meeting of shareholders held on September 13, 2026, its shareholders passed an ordinary resolution approving a one-for-ten reverse stock split (the “Share Consolidation”) of the Company’s issued and unissued ordinary shares of a par value of US$0.001 each (the “Ordinary Shares”), which had previously been recommended by the Company’s board of directors (the “Board”). The Share Consolidation is subject to and conditional upon, and will be effected immediately upon, the Company obtaining clearance or authorization from The Nasdaq Stock Market LLC (“Nasdaq”). Beginning September 28, 2026, the Company’s Ordinary Shares are expected to begin trading on the Nasdaq Capital Market on a split-adjusted basis under the same symbol “FBGL” but with a new CUSIP number, G3337S117, and a new par value of US$0.01 per share.

As a result of the Share Consolidation, each ten Ordinary Shares issued and outstanding will automatically be consolidated into one Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or “street name.” Shareholders holding certificated shares are expected to receive instructions from the Company’s transfer agent, VStock Transfer, LLC, regarding procedures for exchanging share certificates. No fractional shares will be issued upon the Share Consolidation. Instead, the Board is authorized to settle any fractional entitlements, either by rounding them up to the nearest whole share or by arranging for the sale of the shares representing fractions and distributing the net proceeds to the shareholders entitled to them.

The Share Consolidation is intended to increase the per share trading price of the Ordinary Shares to satisfy the US$1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. Prior to the Share Consolidation, the authorized share capital of the Company is US$500,000 divided into 500,000,000 shares with a par value of US$0.001 each, of which 13,500,000 Ordinary Shares are issued and outstanding. Following the Share Consolidation, the authorized share capital of the Company will be US$500,000 divided into 50,000,000 shares with a par value of US$0.01 each, and the Company will have approximately 1,350,000 Ordinary Shares issued and outstanding. Each shareholder’s proportionate ownership interest will remain unchanged, other than for the treatment of fractional entitlements.

About FBS Global Limited

FBS Global Limited (Nasdaq: FBGL) is a construction and building systems specialist focused on high-specification, execution-driven projects across commercial, industrial and public sector markets. The Company delivers technically complex additions and alterations (A&A), retrofitting, insulation systems, lead-lined drywall partitions, false ceiling installations, and integrated interior build-outs.

With more than 30 years of operating experience, FBS targets projects requiring precision engineering, regulatory compliance expertise and coordinated multi-system execution. The Company is focused on expanding its secured project pipeline, increasing participation in public infrastructure works, and driving disciplined, execution-led growth.

For additional information, please visit the Company’s website at https://www.fbsglobal.com.sg/.

Forward-Looking Statements

Certain statements in this release, including statements regarding the receipt of Nasdaq clearance for, and the timing, implementation and expected effects of, the Share Consolidation and the Company’s continued listing on Nasdaq, constitute forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. The words “believe,” “forecast,” “project,” “intend,” “expect,” “plan,” “should,” “would,” and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, any of which could cause the Company to not achieve some or all of its goals or the Company’s previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained from the SEC’s website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release, other than as required by applicable law.

Contact:

FBS Global Limited
Tel: +65 6285778
Email: finebuild@singnet.com.sg

New proprietary framework analyzes 100% of customer interactions to identify the issues driving customer friction and business impact

AUSTIN, Texas, Sept. 24, 2026 (GLOBE NEWSWIRE) — TTEC, a leading global consulting, technology, and managed services company delivering solutions at the intersection of data, AI, and customer experience (CX), today unveiled TTEC CARES, a proprietary quality intelligence framework designed to help organizations move beyond traditional quality assurance scorecards and understand what customers actually experience across every interaction.

TTEC CARES, an acronym for Conversation, Analytics, Resolution, Effort and Sentiment, uses AI-powered conversation analytics to analyze 100% of customer interactions and measure three critical drivers of the customer experience: resolution, effort, and sentiment. Rather than relying on limited survey feedback or sampled quality evaluations, TTEC CARES helps organizations understand whether an issue was resolved, how much effort the customer expended, and how the customer felt throughout the experience.

The framework turns those signals into a unified CARES Score, giving contact center leaders a view of customer experience at the interaction level and at scale.

“Quality assurance has traditionally focused on whether agents follow a process. TTEC CARES shifts the focus to quality intelligence – whether customers achieved their desired outcome and how they experienced the journey,” said Suzi Simango, TTEC’s executive director of quality intelligence. “By measuring resolution, effort, and sentiment together, organizations gain a clearer understanding of what’s driving customer satisfaction, operational performance, and business results.”

From quality scores to customer experience intelligence

Unlike traditional survey programs that often capture feedback from only a small percentage of customers, TTEC CARES can provide visibility across every interaction, helping organizations uncover hidden customer friction, identify coaching opportunities, and surface operational issues in near real time. The framework uses AI-powered conversation analytics to transform customer conversations into actionable business intelligence.

The framework focuses on three core experience signals:

• Resolution: Was the customer’s issue fully resolved?
• Effort: How much customer effort to achieve that outcome?
• Sentiment: How did the customer feel throughout the interaction?

Together, these signals provide a complete view of the customer experience and help organizations move from sampled measurement to scaled intelligence, from reactive coaching to proactive action, and from reporting scores to understanding the drivers behind them.

Early analysis shows how quality intelligence can uncover hidden costs

TTEC has applied the CARES methodology to more than 82,000 customer interactions to date, using resolution, effort, and sentiment data to identify the drivers of dissatisfaction and quantify their business impact. In one analysis for a major travel e-commerce organization, CARES analyzed over 20,000 customer interactions and identified more than 8,500 negative experiences. Targeted improvements identified through the analysis represented over $400,000 in potential annualized cost savings.

TTEC executives will share the vision behind TTEC CARES at the 2026 QATC Annual Conference during their session, “Beyond the Scorecard: Rethinking How Call Centers Measure What Actually Matters.” The presentation will explore why customer outcomes, rather than process adherence alone, are becoming the new standard for measuring contact center performance.

About TTEC
TTEC Holdings, Inc. (NASDAQ: TTEC) is a leading global consulting, technology, and managed services company delivering solutions at the intersection of data, AI, and customer experience. Serving iconic and disruptive brands, TTEC’s outcome-based solutions span the entire enterprise, touch every virtual interaction channel, and improve each step of the customer journey. Leveraging next-generation digital technology, the Company’s TTEC Digital business designs, builds, and operates omnichannel contact center technology, CRM, AI, and analytics solutions. The Company also delivers AI-enhanced customer engagement, customer acquisition and growth, tech support, back-office, and fraud prevention services. Founded in 1982, TTEC’s singular obsession with CX excellence has earned it leading client, customer, and employee satisfaction scores across the globe. The Company’s employees operate on six continents and bring technology and humanity together to deliver happy customers and differentiated business results. To learn more, visit https://ttec.com.

Media Contact
Meredith Matthews
Meredith.matthews@ttec.com